Dr. Mingxing Wei graduated from Beijing Agriculture University in China and has obtained his Ph.D. degree at University of Lyon in France. Then, he went to « Harvard Medical School » in Boston for post-doctoral training. After coming back to France in 1995, Dr. Wei has joined two French biotech companies as a Project Manager and got his HDR degree (the highest university degree in France) at University Paris XIII. Dr. Wei founded the company Cellvax in 2001 and serves as an acting CEO for almost 20 years. Since 2018, Cellvax has performed large GLP toxicology / Biodistribution studies. The studies were performed by Cellvax team and inspected in 2020 by French authority ANSM.